Learning archive

Why Lyft (LYFT) Stock Is Falling Today
  • February 12, 2025

Why Lyft (LYFT) Stock Is Falling Today

Shares of ride sharing service Lyft (NASDAQ: LYFT) fell 14.6% in the pre-market session after the company reported disappointing fourth-quarter results: Its revenue slightly missed, and its EBITDA guidance for the next quarter fell short of Wall Street's estimates. The outlook suggests some bumps in the road ahead, but this quarter still had its bright spots as Lyft blew past analysts' EBITDA and EPS expectations. Expectations had soared earlier in the week after the company signaled a possible

Read More
Why CVS Health (CVS) Stock Is Trading Up Today
  • February 12, 2025

Why CVS Health (CVS) Stock Is Trading Up Today

Shares of diversified healthcare company CVS Health (NYSE:CVS) jumped 16.4% in the morning session after the company reported strong fourth-quarter results that exceeded expectations, with same-store sales significantly surpassing analysts' forecasts and EPS outperforming Wall Street's estimates by a wide margin. Growth was powered by strong performance in the Pharmacy & Consumer Wellness segment​. On the other hand, its full-year EPS guidance missed. Despite this, we think this was a decent qua

Read More
Why Waters Corporation (WAT) Stock Is Nosediving
  • February 12, 2025

Why Waters Corporation (WAT) Stock Is Nosediving

Shares of scientific instruments company Waters Corporation (NYSE:WAT) fell 9% in the morning session after the company reported disappointing fourth quarter results: Its revenue and EPS guidance for next quarter fell short of Wall Street's estimates. whole, was underwhelming. The company highlighted headwinds related to foreign exchange, volume, and inflation. Also, the sales outlook suggests growth will trudge along in the mid-single digits, given foreign exchange pressures.

Read More
Why Gilead Sciences (GILD) Stock Is Trading Up Today
  • February 12, 2025

Why Gilead Sciences (GILD) Stock Is Trading Up Today

Shares of biopharmaceutical company Gilead Sciences (NASDAQ:GILD) jumped 8.6% in the morning session after the company reported impressive fourth-quarter results that exceeded analysts' revenue, EPS, and adjusted operating income estimates. Revenue grew 6%, driven by a 16% increase in HIV product sales and supported by strength in oncology and liver disease products. The momentum is expected to continue into the next year, as full-year EPS guidance surpassed Wall Street estimates, while sales gu

Read More
Analysis-Hotter January inflation jolts markets, dimming rate cut hopes
  • February 12, 2025

Analysis-Hotter January inflation jolts markets, dimming rate cut hopes

Surprisingly strong U.S. inflation in January stoked investor fears that a heating economy and looming tariffs could corner the Federal Reserve, undercutting interest rate-cut hopes and even raising the threat of a hike. U.S. consumer prices increased more than expected in January, reinforcing expectations the central bank will be in no rush to resume cutting interest rates, particularly as economic uncertainty is exacerbated by the expected inflationary impact of U.S. President Donald Trump's tariffs on key U.S. trade partners. Fed Chair Jerome Powell said in congressional testimony this week that the Fed was prepared to keep rates unchanged until inflation resumes its decline.

Read More